Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-08-04. The firm and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. The company has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.
Follow-Up Questions
Medivolve Inc (MEDVF)'in P/E oranı nedir?
Medivolve Inc 'in P/E oranı 0 'dir
MEDVF hissesinin fiyat performansı nasıl?
MEDVF 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Medivolve Inc için ana iş temaları veya sektörler nelerdir?
Medivolve Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Medivolve Inc 'in piyasa değerlemesi nedir?
Medivolve Inc 'in mevcut piyasa değerlemesi $0 'dir
